EMEA-002157-PIP01-17
Key facts
| Active substance |
Recombinant Hepatitis B vaccine
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0342/2019
|
| PIP number |
EMEA-002157-PIP01-17
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Prevention of hepatitis B virus infection
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
VBI Vaccines Inc.
Tel. +1 6137494200 ext.151 |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|